E. Hampton Sessions

793 citations

20 papers · 635 indexed · h-index 16

Impact in

Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Physiology top 5%
- Calcium signaling and nucleotide metabolism

Papers in ⓘ

Molecular Biology 13
- Melanoma and MAPK Pathways 5
- Protein Kinase Regulation and GTPase Signaling 5
Organic Chemistry 9
- Synthesis and biological activity 3
- Quinazolinone synthesis and applications 2

Co-authors: Dennis L. Wright (2 shared papers)Ion Ghiviriga (2 shared papers)Peter A. Jacobi (2 shared papers)Claudia Ruiz (5 shared papers)Philip V. LoGrasso (5 shared papers)Jennifer Pocas (5 shared papers)Lin Li (5 shared papers)Thomas D. Bannister (5 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)Organic Letters (4 papers)Nature Communications (2 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations: United States Japan Germany

In The Last Decade

E. Hampton Sessions

20 papers receiving 630 citations

Peers

Countries citing papers authored by E. Hampton Sessions

Since Specialization

Citations

This map shows the geographic impact of E. Hampton Sessions's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Hampton Sessions with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Hampton Sessions more than expected).

Fields of papers citing papers by E. Hampton Sessions

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Hampton Sessions. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Hampton Sessions. The network helps show where E. Hampton Sessions may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Hampton Sessions, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Hampton Sessions Line = papers co-authored together E. Hampton Sessions links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Boosting NAD+ with a small molecule that activates NAMPT Nature Communications ·Stephen J. Gardell, Meghan Hopf, Asima Khan, Mauro Dispagna, E. Hampton Sessions, Rebecca Falter, Nidhi Kapoor, Jeanne K. Brooks, Jeffrey A. Culver, Chris Petucci, Chen-Ting Ma, Steven E. Cohen, Jun Tanaka, Emmanuel S. Burgos, Jennifer S. Hirschi, Steven R. Smith, Eduard Sergienko, Anthony B. Pinkerton	2019	121
2	Benzimidazole- and benzoxazole-based inhibitors of Rho kinase Bioorganic & Medicinal Chemistry Letters ·E. Hampton Sessions, Yan Yin, Thomas D. Bannister, Amiee Weiser, Evelyn Griffin, Jennifer Pocas, Michael D. Cameron, Claudia Ruiz, Lin Li, Stephan C. Schürer, Thomas Schröter, Philip V. LoGrasso, Yangbo Feng	2008	82
3	Studies on Inducers of Nerve Growth Factor: Synthesis of the Cyathin Core Organic Letters ·Dennis L. Wright, Christopher R. Whitehead, E. Hampton Sessions, Ion Ghiviriga, Dean A. Frey	1999	61
4	Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme Nature Communications ·Zongyang Lv, Lingmin Yuan, James H. Atkison, Katelyn Williams, Ramir Vega, E. Hampton Sessions, Daniela Divlianska, Christopher Davies, Yuan Chen, Shaun K. Olsen	2018	47
5	Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB Activation ACS Medicinal Chemistry Letters ·Pasha M. Khan, Ricardo G. Correa, Daniela Divlianska, Satyamaheshwar Peddibhotla, E. Hampton Sessions, Gavin Magnuson, Brock Brown, Eigo Suyama, Hongbin Yuan, Arianna Mangravita-Novo, Michael Vicchiarelli, Ying Su, Stefan Vasile, Layton H. Smith, Paul Diaz, John C. Reed, Gregory P. Roth	2011	47
6	Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I) Bioorganic & Medicinal Chemistry Letters ·Sarwat Chowdhury, E. Hampton Sessions, Jennifer Pocas, Wayne Grant, Thomas Schröter, Lin Li, Claudia Ruiz, Michael D. Cameron, Stephan C. Schürer, Philip V. LoGrasso, Thomas D. Bannister, Yangbo Feng	2011	38
7	Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·X. M. Fang, Yen‐Ting Chen, E. Hampton Sessions, Sarwat Chowdhury, Tomáš Vojkovský, Yan Yin, Jennifer Pocas, Wayne Grant, Thomas Schröter, Lin Li, Claudia Ruiz, Michael D. Cameron, Philip V. LoGrasso, Thomas D. Bannister, Yangbo Feng	2011	27
8	Two-Step Electrochemical Annulation for the Assembly of Polycyclic Systems Organic Letters ·Christopher R. Whitehead, E. Hampton Sessions, Ion Ghiviriga, Dennis L. Wright	2002	24
9	Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors ACS Medicinal Chemistry Letters ·Bernhard C. Lechtenberg, Peter D. Mace, E. Hampton Sessions, Robert Williamson, Romain Stalder, Yann Wallez, Gregory P. Roth, Stefan J. Riedl, Elena B. Pasquale	2017	24
10	Studies on the Synthesis of Furanosteroids. I. Viridin Models Organic Letters ·E. Hampton Sessions, Peter A. Jacobi	2006	22
11	Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress Journal of Pharmacology and Experimental Therapeutics ·R. Jason Kirby, Daniela Divlianska, Kanupriya Whig, Nadezda Bryan, Camilo J. Morfa, Ada Koo, Becky Hood, Kevin Nguyen, Patrick Maloney, Satayamaheshwar Peddibhotla, E. Hampton Sessions, Paul Hershberger, Layton H. Smith, Siobhan Malany	2017	21
12	The development of benzimidazoles as selective rho kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·E. Hampton Sessions, Michael Smolinski, Bo Wang, B. Frąckowiak, Sarwat Chowdhury, Yan Yin, Yen‐Ting Chen, Claudia Ruiz, Lin Li, Jennifer Pocas, Thomas Schröter, Michael D. Cameron, Philip V. LoGrasso, Yangbo Feng, Thomas D. Bannister	2010	20
13	Discovery and optimization of indole and 7-azaindoles as Rho kinase (ROCK) inhibitors (Part-II) Bioorganic & Medicinal Chemistry Letters ·E. Hampton Sessions, Sarwat Chowdhury, Yan Yin, Jennifer Pocas, Wayne Grant, Thomas Schröter, Lin Li, Claudia Ruiz, Michael D. Cameron, Philip V. LoGrasso, Thomas D. Bannister, Yangbo Feng	2011	19
14	Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells Cancer Letters ·Yongmei Feng, E. Hampton Sessions, Fan Zhang, Fuqiang Ban, Veronica Placencio-Hickok, Chen-Ting Ma, Fu‐Yue Zeng, Ian Pass, David Terry, G. Cadwell, Laurie A. Bankston, Robert Liddington, Thomas D.Y. Chung, Anthony B. Pinkerton, Eduard Sergienko, Martin Gleave, Neil A. Bhowmick, Michael R. Jackson, Artem Cherkasov, Ze’ev A. Ronai	2019	18
15	Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma Bioorganic & Medicinal Chemistry Letters ·Satyamaheshwar Peddibhotla, Paul Hershberger, R. Jason Kirby, Eliot Sugarman, Patrick Maloney, E. Hampton Sessions, Daniela Divlianska, Camilo J. Morfa, David Terry, Anthony B. Pinkerton, Layton H. Smith, Siobhan Malany	2019	15
16	Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators Bioorganic & Medicinal Chemistry Letters ·Anthony B. Pinkerton, E. Hampton Sessions, Paul Hershberger, Patrick Maloney, Satyamaheshwar Peddibhotla, Meghan Hopf, Eduard Sergienko, Chen-Ting Ma, Layton H. Smith, Michael R. Jackson, Jun Tanaka, Takashi Tsuji, Mayuko Akiu, Steven E. Cohen, Tsuyoshi Nakamura, Stephen J. Gardell	2021	15
17	Furanosteroid Studies. Stereoselective Synthesis of the A,B,E-Ring Core of Wortmannin Organic Letters ·E. Hampton Sessions, Roger T. O’Connor, Peter A. Jacobi	2007	13
18	Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition Bioorganic & Medicinal Chemistry Letters ·Mayuko Akiu, Takashi Tsuji, Yoshitaka Sogawa, Koji Terayama, Mika Yokoyama, Jun Tanaka, Daigo Asano, Ken Sakurai, Eduard Sergienko, E. Hampton Sessions, Stephen J. Gardell, Anthony B. Pinkerton, Tsuyoshi Nakamura	2021	9
19	Synthesis and physicochemical characterization of novel phenotypic probes targeting the nuclear factor-kappa B signaling pathway Beilstein Journal of Organic Chemistry ·Paul Hershberger, Satyamaheshwar Peddibhotla, E. Hampton Sessions, Daniela Divlianska, Ricardo G. Correa, Anthony B. Pinkerton, John C. Reed, Gregory P. Roth	2013	6
20	Measurement of Pyridine Nucleotides in Biological Samples Using LC-MS/MS Methods in molecular biology ·Chris Petucci, Jeffrey A. Culver, Nidhi Kapoor, E. Hampton Sessions, Daniela Divlianska, Stephen J. Gardell	2019	6

About E. Hampton Sessions

E. Hampton Sessions is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Geriatrics and Gerontology and Physiology, having authored 20 papers that have together received 635 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Sirtuins and Resveratrol in Medicine (4 papers), Synthesis and biological activity (3 papers), PARP inhibition in cancer therapy (3 papers), Calcium signaling and nucleotide metabolism (3 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Quinazolinone synthesis and applications (2 papers). The work is most often cited by research in Geriatrics and Gerontology (108 citations), Physiology (66 citations), Organic Chemistry (240 citations), Molecular Biology (295 citations) and Oncology (117 citations). E. Hampton Sessions has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Dennis L. Wright, Ion Ghiviriga, Peter A. Jacobi, Claudia Ruiz, Philip V. LoGrasso, Jennifer Pocas, Lin Li, Thomas D. Bannister, Michael D. Cameron and Thomas Schröter. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Organic Letters, Nature Communications, ACS Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact